{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:39:24Z","timestamp":1773146364033,"version":"3.50.1"},"reference-count":55,"publisher":"Informa UK Limited","issue":"4-5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Ophthalmology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.3109\/08820538.2011.588665","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T10:33:51Z","timestamp":1317292431000},"page":"295-303","source":"Crossref","is-referenced-by-count":34,"title":["The Use of Biologic Agents in the Treatment of Ocular Manifestations of Behcet\u2019s Disease"],"prefix":"10.3109","volume":"26","author":[{"given":"Nicole R.","family":"Benitah","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Papaliodis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,9,29]]},"reference":[{"issue":"927","key":"e_1_3_2_2_1","first-page":"258","article-title":"Virus interference. I. The interferon. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character","volume":"147","author":"Isaacs A","year":"1957","unstructured":"Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. Royal Society. Sep 12 1957;147(927):258\u2013267.","journal-title":"Royal Society"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00407749"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.09.010"},{"issue":"4","key":"e_1_3_2_5_1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Behcet disease: A randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy E","year":"2002","unstructured":"Alpsoy E, Durusoy C, Yilmaz E, et al. Interferon alfa-2a in the treatment of Behcet disease: A randomized placebo-controlled and double-blind study. Arch. Dermatol. Apr 2002;138(4):467\u2013471.","journal-title":"Arch. Dermatol"},{"issue":"11","key":"e_1_3_2_6_1","article-title":"Interferon alfa combined with azathioprine for the uveitis of Behcet\u2019s disease: An open study","volume":"4","author":"Hamuryudan V","year":"2002","unstructured":"Hamuryudan V, Ozyazgan Y, Fresko Y, Mat C, Yurdakul S, Yazici H. Interferon alfa combined with azathioprine for the uveitis of Behcet\u2019s disease: An open study. The Israel Medical Association Journal: IMAJ. Nov 2002;4(11 Suppl):928\u2013930.","journal-title":"The Israel Medical Association Journal: IMAJ"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.5.492"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Tugal-Tutkun I Guney-Tefekli E Urgancioglu M. Results of interferon-alfa therapy in patients with Behcet uveitis. Graefe\u2019s Archive for Clinical and Experimental Ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie. Dec 2006;244(12):1692\u20131695.","DOI":"10.1007\/s00417-006-0346-y"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.101550"},{"issue":"6","key":"e_1_3_2_10_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.08.038","article-title":"Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease","volume":"146","author":"Gueudry J","year":"2008","unstructured":"Gueudry J, Wechsler B, Terrada C, et al. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease. Am. J. Ophthalmol. Dec 2008;146(6):837\u2013844 e831.","journal-title":"Am. J. Ophthalmol"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.11.022"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27581"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem199"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.01.005"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/09629350220131935"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000055677"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05497-6"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.560"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00406-8"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_111"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_112"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-006-0425-y"},{"issue":"4","key":"e_1_3_2_23_1","first-page":"S14","article-title":"Infliximab in refractory uveitis due to Behcet\u2019s disease","volume":"22","author":"Wechsler B","year":"2004","unstructured":"Wechsler B, Sable-Fourtassou R, Bodaghi B, et al. Infliximab in refractory uveitis due to Behcet\u2019s disease. Clin. Exp. Rheumatol. Jul-Aug 2004;22(4 Suppl 34):S14\u201316.","journal-title":"Clin. Exp. Rheumatol"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0755-4982(05)84079-5"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1423.050"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-006-0424-z"},{"issue":"5","key":"e_1_3_2_27_1","first-page":"930","article-title":"Successful treatment of severe Behcet\u2019s disease with infliximab in an Italian Olympic athlete","volume":"35","author":"Olivieri I","year":"2008","unstructured":"Olivieri I, Latanza L, Siringo S, Peruz G, Di Iorio V. Successful treatment of severe Behcet\u2019s disease with infliximab in an Italian Olympic athlete. The Journal of Rheumatology. May 2008;35(5):930\u2013932.","journal-title":"The Journal of Rheumatology"},{"issue":"4","key":"e_1_3_2_28_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3899\/jrheum.081063","article-title":"Long-lasting remission of severe Behcet\u2019s disease after the end of infliximab therapy","volume":"36","author":"Olivieri I","year":"2009","unstructured":"Olivieri I, Padula A, LecceseP, D\u2019Angelo S, Giasi V. Long-lasting remission of severe Behcet\u2019s disease after the end of infliximab therapy. The Journal of Rheumatology. Apr 2009;36(4):855.","journal-title":"The Journal of Rheumatology"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000277928"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-010-9372-1"},{"key":"e_1_3_2_31_1","article-title":"Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet\u2019s disease on infliximab therapy","author":"Keino H","year":"2010","unstructured":"Keino H, Okada AA, Watanabe T, Taki W. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet\u2019s disease on infliximab therapy. The British Journal of Pphthalmology. Dec 22 2010.","journal-title":"The British Journal of Pphthalmology"},{"issue":"7","key":"e_1_3_2_32_1","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet\u2019s disease with refractory uveoretinitis","volume":"31","author":"Ohno S","year":"2004","unstructured":"Ohno S, Nakamura S, Hori S, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet\u2019s disease with refractory uveoretinitis. The Journal of Rheumatology. Jul 2004;31(7):1362\u20131368.","journal-title":"The Journal of Rheumatology"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-5-200403020-00025"},{"issue":"3","key":"e_1_3_2_34_1","first-page":"427","article-title":"Hamra R, Homeidan F, et al. The efficacy of a single dose of infliximab in the treatment of Behcet\u2019s disease uveitis","volume":"23","author":"Arayssi T","year":"2005","unstructured":"Arayssi T, Hamra R, Homeidan F, et al. The efficacy of a single dose of infliximab in the treatment of Behcet\u2019s disease uveitis. Clin. Exp. Rheumatol. May-Jun 2005;23(3):427.","journal-title":"Clin. Exp. Rheumatol"},{"issue":"3","key":"e_1_3_2_35_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10792-006-9006-9","article-title":"Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet\u2019s disease","volume":"26","author":"Abu El-Asrar AM","year":"2005","unstructured":"Abu El-Asrar AM, Abboud EB, Aldibhi H, Al-Arfaj A. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet\u2019s disease. Int. Ophthalmol. Jun 2005;26(3):83\u201392.","journal-title":"Int. Ophthalmol"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21231"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem101"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0606-8"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1213-z"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq366"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.09.010"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.158840"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067210401400515"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2010.0031"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.168856"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-010-0859-0"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283126d20"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep146"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2010.486520"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200235"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0857-5"},{"issue":"2","key":"e_1_3_2_52_1","article-title":"Behcet\u2019s disease: A new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis PP","year":"2002","unstructured":"Sfikakis PP. Behcet\u2019s disease: A new target for anti-tumour necrosis factor treatment. Ann. Rheum. Dis. Nov 2002;61 Suppl 2:ii51\u201353.","journal-title":"Ann. Rheum. Dis"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702352"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1178-y"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0057-9"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01546.x"}],"container-title":["Seminars in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08820538.2011.588665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:16:13Z","timestamp":1753100173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08820538.2011.588665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":55,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.3109\/08820538.2011.588665"],"URL":"https:\/\/doi.org\/10.3109\/08820538.2011.588665","relation":{},"ISSN":["0882-0538","1744-5205"],"issn-type":[{"value":"0882-0538","type":"print"},{"value":"1744-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}